Elite Universal Test
Bank: Advanced Practice
Nursing in the Care of
Older Adults
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Hard-deck definitions,
2026 AGS Beers Criteria, core screening metrics, physiological aging baselines, and
primary Signal Symptoms.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Clinical pivots, GOLD
2026 COPD criteria, ESC 2026 Hypertension targets, HFpEF management, and
acute-on-chronic physiological presentations.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-acuity multi-morbidity,
end-of-life ethics, unrepresented patient policies, CMS facility transitions, and
GLP-1/biologic cascade failures.
PART I: THE PRIMER
Mastering this highly targeted 88-point clinical gauntlet translates directly to elite advanced
practice nursing, forging the diagnostic intuition required to safely manage highly complex older
adults and averting iatrogenic harm. This document replaces rote memorization with deep,
synthesized understanding.
● The 4Ms Framework: Mentation, Medications, Mobility, What Matters. This is the global
standard baseline for all geriatric encounters.
● The 2026 Deprescribing Mandate: If a symptom is new, it is an adverse drug event until
proven otherwise. The 2026 AGS Beers Criteria heavily emphasizes non-pharmacologic
alternatives.
● Frailty Modifies Targets: Life expectancy and functional status universally override strict
numeric laboratory targets.
Guideline Entity (2026) Target Population Primary 2026/2027 Citation
Clinical Target/Protocol
ADA (Diabetes) Complex / Frail A1C < 8.0%; Avoid
hypoglycemia / TIR
~50%
ESC (Hypertension) Frail / > 80 years SBP 130–140 mmHg, if
tolerated
,Guideline Entity (2026) Target Population Primary 2026/2027 Citation
Clinical Target/Protocol
(Monotherapy)
GOLD (COPD) All Older Adults Single moderate
exacerbation triggers
escalation
AHA/ACC (HFpEF) All Older Adults SGLT2i + Non-steroidal
MRA (Finerenone)
CDC (Vaccines) Adults > 75 years One-time RSV; Annual
High-Dose Influenza
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: An 82-year-old female with osteoarthritis reports new-onset insomnia. Based on the
2025/2026 AGS Beers Criteria Alternatives List, which intervention is the FIRST line
recommendation? A) Zolpidem 5mg at bedtime B) Diphenhydramine 25mg PRN C) Cognitive
Behavioral Therapy for Insomnia (CBT-I) D) Cyclobenzaprine 5mg at bedtime
● The Answer: C (Cognitive Behavioral Therapy for Insomnia (CBT-I))
● Distractor Analysis:
○ A is incorrect: Z-drugs increase fall and delirium risk without clinically significant
sleep improvements.
○ B is incorrect: First-generation antihistamines are highly anticholinergic and
exacerbate cognitive decline.
○ D is incorrect: Muscle relaxants are highly sedating and strictly avoided.
The Mentor's Analysis: Non-pharmacologic alternatives are the 2026 standard for geriatric
insomnia. Professional/Academic Intuition: Pills do not cure poor sleep hygiene; behavior
does.
Q2: An 88-year-old male with type 2 diabetes and severe cognitive impairment resides in a
memory care unit. According to the ADA 2026 Standards, what is the MOST APPROPRIATE
glycemic goal? A) Hemoglobin A1c strictly < 7.0% B) Fasting glucose between 80-130 mg/dL C)
Avoidance of hypoglycemia and symptomatic hyperglycemia D) Time in Range (TIR) > 70% via
continuous glucose monitor
● The Answer: C (Avoidance of hypoglycemia and symptomatic hyperglycemia)
● Distractor Analysis:
○ A is incorrect: This target is reserved for healthy older adults with intact cognition.
○ B is incorrect: This fasting range is too stringent for very complex/poor health
patients.
○ D is incorrect: A 70% TIR is standard for healthy adults; frail adults require looser
metrics.
The Mentor's Analysis: In end-stage illness, strict metabolic targets cause iatrogenic harm.
Professional/Academic Intuition: In severe frailty, survival overrides strict normalization.
Q3: A frail 84-year-old female presents for a blood pressure check. She has no history of
cardiovascular disease. Under the 2026 ESC Hypertension guidelines, what is her target
systolic blood pressure (SBP)? A) < 120 mmHg B) 130–140 mmHg, if tolerated C) 140–150
mmHg universally D) < 130 mmHg
● The Answer: B (130–140 mmHg, if tolerated)
, ● Distractor Analysis:
○ A is incorrect: This target risks orthostatic hypotension and falls in frail elders.
○ C is incorrect: This is a legacy target from outdated 2023 ESH guidelines.
○ D is incorrect: This is the target for younger or exceptionally healthy older adults.
The Mentor's Analysis: Advanced age and frailty alter arterial stiffness and pharmacokinetics.
Professional/Academic Intuition: Treat the patient's perfusion, not just the pressure.
Q4: A 76-year-old male is newly diagnosed with Heart Failure with preserved Ejection Fraction
(HFpEF). Based on 2026 AHA/ACC guidelines, which medication class holds a Class 2a
recommendation for IMMEDIATELY improving outcomes? A) Loop Diuretics B) Beta-Blockers
C) Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) D) Calcium Channel Blockers
● The Answer: C (Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i))
● Distractor Analysis:
○ A is incorrect: Loop diuretics manage volume overload but do not alter disease
trajectory.
○ B is incorrect: Beta-blockers lack robust mortality benefit in pure HFpEF.
○ D is incorrect: CCBs are not primary disease-modifying agents in HFpEF.
The Mentor's Analysis: SGLT2 inhibitors have revolutionized HFpEF management by
fundamentally altering cardiometabolic risk. Professional/Academic Intuition: SGLT2 inhibitors
are the foundational pillar of modern HFpEF therapy.
Q5: A 71-year-old patient with COPD had one moderate exacerbation treated with oral
corticosteroids three months ago. Based on the 2026 GOLD Report, what is the MOST
LOGICAL clinical action? A) Maintain current short-acting bronchodilator therapy B) Escalate
maintenance pharmacological therapy immediately C) Prescribe prophylactic daily azithromycin
D) Initiate continuous home oxygen therapy
● The Answer: B (Escalate maintenance pharmacological therapy immediately)
● Distractor Analysis:
○ A is incorrect: The 2026 guidelines identify a single moderate exacerbation as a
trigger for escalation.
○ C is incorrect: Chronic macrolides are reserved for highly specific, refractory
phenotypes.
○ D is incorrect: Oxygen is indicated for severe resting hypoxemia, not solely
exacerbation history.
The Mentor's Analysis: The threshold for intervention has dropped; one exacerbation signals a
failing regimen. Professional/Academic Intuition: Do not wait for a second attack; a single
exacerbation proves disease instability.
Q6: A 75-year-old healthy female asks which respiratory vaccines she needs for the upcoming
winter. According to 2026 CDC guidelines, which is MOST ACCURATE? A) She requires the
RSV vaccine annually. B) She requires a one-time RSV vaccine and an annual High-Dose
Influenza vaccine. C) She requires the live-attenuated influenza vaccine (LAIV3). D) She
requires the pneumococcal vaccine every year.
● The Answer: B (She requires a one-time RSV vaccine and an annual High-Dose
Influenza vaccine.)
● Distractor Analysis:
○ A is incorrect: The RSV vaccine is currently a one-time administration for older
adults >75.
○ C is incorrect: LAIV3 is contraindicated in older adults.
○ D is incorrect: Pneumococcal vaccines are not dosed annually.
The Mentor's Analysis: Immunosenescence demands high-antigen load vaccines (like HD-Flu)
Bank: Advanced Practice
Nursing in the Care of
Older Adults
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Hard-deck definitions,
2026 AGS Beers Criteria, core screening metrics, physiological aging baselines, and
primary Signal Symptoms.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Clinical pivots, GOLD
2026 COPD criteria, ESC 2026 Hypertension targets, HFpEF management, and
acute-on-chronic physiological presentations.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: High-acuity multi-morbidity,
end-of-life ethics, unrepresented patient policies, CMS facility transitions, and
GLP-1/biologic cascade failures.
PART I: THE PRIMER
Mastering this highly targeted 88-point clinical gauntlet translates directly to elite advanced
practice nursing, forging the diagnostic intuition required to safely manage highly complex older
adults and averting iatrogenic harm. This document replaces rote memorization with deep,
synthesized understanding.
● The 4Ms Framework: Mentation, Medications, Mobility, What Matters. This is the global
standard baseline for all geriatric encounters.
● The 2026 Deprescribing Mandate: If a symptom is new, it is an adverse drug event until
proven otherwise. The 2026 AGS Beers Criteria heavily emphasizes non-pharmacologic
alternatives.
● Frailty Modifies Targets: Life expectancy and functional status universally override strict
numeric laboratory targets.
Guideline Entity (2026) Target Population Primary 2026/2027 Citation
Clinical Target/Protocol
ADA (Diabetes) Complex / Frail A1C < 8.0%; Avoid
hypoglycemia / TIR
~50%
ESC (Hypertension) Frail / > 80 years SBP 130–140 mmHg, if
tolerated
,Guideline Entity (2026) Target Population Primary 2026/2027 Citation
Clinical Target/Protocol
(Monotherapy)
GOLD (COPD) All Older Adults Single moderate
exacerbation triggers
escalation
AHA/ACC (HFpEF) All Older Adults SGLT2i + Non-steroidal
MRA (Finerenone)
CDC (Vaccines) Adults > 75 years One-time RSV; Annual
High-Dose Influenza
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: An 82-year-old female with osteoarthritis reports new-onset insomnia. Based on the
2025/2026 AGS Beers Criteria Alternatives List, which intervention is the FIRST line
recommendation? A) Zolpidem 5mg at bedtime B) Diphenhydramine 25mg PRN C) Cognitive
Behavioral Therapy for Insomnia (CBT-I) D) Cyclobenzaprine 5mg at bedtime
● The Answer: C (Cognitive Behavioral Therapy for Insomnia (CBT-I))
● Distractor Analysis:
○ A is incorrect: Z-drugs increase fall and delirium risk without clinically significant
sleep improvements.
○ B is incorrect: First-generation antihistamines are highly anticholinergic and
exacerbate cognitive decline.
○ D is incorrect: Muscle relaxants are highly sedating and strictly avoided.
The Mentor's Analysis: Non-pharmacologic alternatives are the 2026 standard for geriatric
insomnia. Professional/Academic Intuition: Pills do not cure poor sleep hygiene; behavior
does.
Q2: An 88-year-old male with type 2 diabetes and severe cognitive impairment resides in a
memory care unit. According to the ADA 2026 Standards, what is the MOST APPROPRIATE
glycemic goal? A) Hemoglobin A1c strictly < 7.0% B) Fasting glucose between 80-130 mg/dL C)
Avoidance of hypoglycemia and symptomatic hyperglycemia D) Time in Range (TIR) > 70% via
continuous glucose monitor
● The Answer: C (Avoidance of hypoglycemia and symptomatic hyperglycemia)
● Distractor Analysis:
○ A is incorrect: This target is reserved for healthy older adults with intact cognition.
○ B is incorrect: This fasting range is too stringent for very complex/poor health
patients.
○ D is incorrect: A 70% TIR is standard for healthy adults; frail adults require looser
metrics.
The Mentor's Analysis: In end-stage illness, strict metabolic targets cause iatrogenic harm.
Professional/Academic Intuition: In severe frailty, survival overrides strict normalization.
Q3: A frail 84-year-old female presents for a blood pressure check. She has no history of
cardiovascular disease. Under the 2026 ESC Hypertension guidelines, what is her target
systolic blood pressure (SBP)? A) < 120 mmHg B) 130–140 mmHg, if tolerated C) 140–150
mmHg universally D) < 130 mmHg
● The Answer: B (130–140 mmHg, if tolerated)
, ● Distractor Analysis:
○ A is incorrect: This target risks orthostatic hypotension and falls in frail elders.
○ C is incorrect: This is a legacy target from outdated 2023 ESH guidelines.
○ D is incorrect: This is the target for younger or exceptionally healthy older adults.
The Mentor's Analysis: Advanced age and frailty alter arterial stiffness and pharmacokinetics.
Professional/Academic Intuition: Treat the patient's perfusion, not just the pressure.
Q4: A 76-year-old male is newly diagnosed with Heart Failure with preserved Ejection Fraction
(HFpEF). Based on 2026 AHA/ACC guidelines, which medication class holds a Class 2a
recommendation for IMMEDIATELY improving outcomes? A) Loop Diuretics B) Beta-Blockers
C) Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) D) Calcium Channel Blockers
● The Answer: C (Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i))
● Distractor Analysis:
○ A is incorrect: Loop diuretics manage volume overload but do not alter disease
trajectory.
○ B is incorrect: Beta-blockers lack robust mortality benefit in pure HFpEF.
○ D is incorrect: CCBs are not primary disease-modifying agents in HFpEF.
The Mentor's Analysis: SGLT2 inhibitors have revolutionized HFpEF management by
fundamentally altering cardiometabolic risk. Professional/Academic Intuition: SGLT2 inhibitors
are the foundational pillar of modern HFpEF therapy.
Q5: A 71-year-old patient with COPD had one moderate exacerbation treated with oral
corticosteroids three months ago. Based on the 2026 GOLD Report, what is the MOST
LOGICAL clinical action? A) Maintain current short-acting bronchodilator therapy B) Escalate
maintenance pharmacological therapy immediately C) Prescribe prophylactic daily azithromycin
D) Initiate continuous home oxygen therapy
● The Answer: B (Escalate maintenance pharmacological therapy immediately)
● Distractor Analysis:
○ A is incorrect: The 2026 guidelines identify a single moderate exacerbation as a
trigger for escalation.
○ C is incorrect: Chronic macrolides are reserved for highly specific, refractory
phenotypes.
○ D is incorrect: Oxygen is indicated for severe resting hypoxemia, not solely
exacerbation history.
The Mentor's Analysis: The threshold for intervention has dropped; one exacerbation signals a
failing regimen. Professional/Academic Intuition: Do not wait for a second attack; a single
exacerbation proves disease instability.
Q6: A 75-year-old healthy female asks which respiratory vaccines she needs for the upcoming
winter. According to 2026 CDC guidelines, which is MOST ACCURATE? A) She requires the
RSV vaccine annually. B) She requires a one-time RSV vaccine and an annual High-Dose
Influenza vaccine. C) She requires the live-attenuated influenza vaccine (LAIV3). D) She
requires the pneumococcal vaccine every year.
● The Answer: B (She requires a one-time RSV vaccine and an annual High-Dose
Influenza vaccine.)
● Distractor Analysis:
○ A is incorrect: The RSV vaccine is currently a one-time administration for older
adults >75.
○ C is incorrect: LAIV3 is contraindicated in older adults.
○ D is incorrect: Pneumococcal vaccines are not dosed annually.
The Mentor's Analysis: Immunosenescence demands high-antigen load vaccines (like HD-Flu)
